Open AccessEfficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM study
Author(s) -
Xin Hong,
Yuqin Song,
Yuankai Shi,
Qingyuan Zhang,
Wei Guo,
Gang Wu,
Junmin Li,
Jifeng Feng,
Anastasiia Kinkolykh,
Andrea Knapp,
Tongyu Lin
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001737
Subject(s) - obinutuzumab , follicular lymphoma , medicine , subgroup analysis , follicular phase , oncology , lymphoma , gastroenterology , rituximab , meta analysis